Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 48

2.

C3b generation is affected by the structure of the O-antigen polysaccharide in lipopolysaccharide from salmonellae.

Jimenez-Lucho VE, Joiner KA, Foulds J, Frank MM, Leive L.

J Immunol. 1987 Aug 15;139(4):1253-9.

PMID:
2440949
3.

Lipopolysaccharide size and distribution determine serum resistance in Salmonella montevideo.

Grossman N, Schmetz MA, Foulds J, Klima EN, Jimenez-Lucho VE, Leive LL, Joiner KA.

J Bacteriol. 1987 Feb;169(2):856-63. Erratum in: J Bacteriol 1987 Jun;169(6):2911. Jiminez V [corrected to Jimenez-Lucho VE].

4.

Electrophoretic separation of lipopolysaccharide monomers differing in polysaccharide length.

Goldman RC, Leive L.

Methods Enzymol. 1987;138:267-75. No abstract available.

PMID:
2439873
5.

Lipopolysaccharide nomenclature--past, present, and future.

Hitchcock PJ, Leive L, Mäkelä PH, Rietschel ET, Strittmatter W, Morrison DC.

J Bacteriol. 1986 Jun;166(3):699-705. Review. No abstract available.

6.
7.
10.
11.

Tetracyclines of various hydrophobicities as a probe for permeability of Escherichia coli outer membranes.

Leive L, Telesetsky S, Coleman WG Jr, Carr D.

Antimicrob Agents Chemother. 1984 May;25(5):539-44.

13.

A quantitative analysis of C3 binding to O-antigen capsule, lipopolysaccharide, and outer membrane protein of E. coli 0111B4.

Joiner KA, Goldman R, Schmetz M, Berger M, Hammer CH, Frank MM, Leive L.

J Immunol. 1984 Jan;132(1):369-75.

PMID:
6197449
16.

Complement activation by polysaccharide of lipopolysaccharide: an important virulence determinant of salmonellae.

Liang-Takasaki CJ, Saxén H, Mäkelä PH, Leive L.

Infect Immun. 1983 Aug;41(2):563-9.

17.
18.
19.

A surface polysaccharide of Escherichia coli O111 contains O-antigen and inhibits agglutination of cells by O-antiserum.

Goldman RC, White D, Orskov F, Orskov I, Rick PD, Lewis MS, Bhattacharjee AK, Leive L.

J Bacteriol. 1982 Sep;151(3):1210-21.

20.
21.
22.

Identification of outer membrane proteins, including known lymphocyte mitogens, as the endotoxin protein of Escherichia coli 0111.

Goldman RC, White D, Leive L.

J Immunol. 1981 Oct;127(4):1290-4. No abstract available.

PMID:
7024405
23.
24.
25.
26.
27.

Genetic analysis of Escherichia coli O111:B4, a strain of medical and biochemical interest.

Coleman WG Jr, Goebel PJ, Leive L.

J Bacteriol. 1977 May;130(2):656-60.

28.
29.
30.
31.

Biochemistry registry.

Leive L.

Science. 1975 Jan 31;187(4174):300. No abstract available.

PMID:
17814254
32.

The barrier function of the gram-negative envelope.

Leive L.

Ann N Y Acad Sci. 1974 May 10;235(0):109-29. Review. No abstract available.

PMID:
4212391
33.

Status of women microbiologists.

Kashket ER, Robbins ML, Leive L, Huang AS.

Science. 1974 Feb 8;183(4124):488-94.

PMID:
4809561
34.

Enlightened employment tactics.

Leive L, Singer MF.

Science. 1971 Apr 16;172(3980):214. No abstract available.

PMID:
17847235
35.
36.
37.

Release from Escherichia coli of a galactosyltransferase complex active in lipopolysaccharide synthesis.

Levy SB, Leive L.

J Biol Chem. 1970 Feb 10;245(3):585-94. No abstract available.

38.

Physical, chemical, and immunological properties of lipopolysaccharide released from Escherichia coli by ethylenediaminetetraacetate.

Leive L, Shovlin VK, Mergenhagen SE.

J Biol Chem. 1968 Dec 25;243(24):6384-91. No abstract available.

39.

An equilibrium between two fractions of lipopolysaccharide in Escherichia coli.

Levy SB, Leive L.

Proc Natl Acad Sci U S A. 1968 Dec;61(4):1435-9. No abstract available.

40.

Studies on the permeability change produced in coliform bacteria by ethylenediaminetetraacetate.

Leive L.

J Biol Chem. 1968 May 10;243(9):2373-80. No abstract available.

41.

Controlling EDTA treatment to produce permeable Escherichia coli with normal metabolic processes.

Leive L, Kollin V.

Biochem Biophys Res Commun. 1967 Jul 21;28(2):229-36. No abstract available.

PMID:
4166571
42.

Synthesis, utilization and degradation of lactose operon mRNA in Escherichia coli.

Leive L, Kollin V.

J Mol Biol. 1967 Mar 14;24(2):247-59. No abstract available.

PMID:
4961803
43.

Release of lipopolysaccharide by EDTA treatment of E. coli.

Leive L.

Biochem Biophys Res Commun. 1965 Nov 22;21(4):290-6. No abstract available.

PMID:
4159978
44.

Evidence for a gradient of exogenous and endogenous diaminopimelate in Escherichia coli.

Leive L, Davis BD.

J Biol Chem. 1965 Nov;240(11):4370-6. No abstract available.

45.

The transport of diaminopimelate and cystine in Escherichia coli.

Leive L, Davis BD.

J Biol Chem. 1965 Nov;240(11):4362-9. No abstract available.

46.

A NOVEL EFFECT OF ACTINOMYCIN D IN PREVENTING BACTERIOPHAGE T4 MATURATION IN ESCHERICHIA COLI.

KORN D, PROTASS JJ, LEIVE L.

Biochem Biophys Res Commun. 1965 May 3;19:473-81. No abstract available.

PMID:
14338995
47.

A NONSPECIFIC INCREASE IN PERMEABILITY IN ESCHERICHIA COLI PRODUCED BY EDTA.

LEIVE L.

Proc Natl Acad Sci U S A. 1965 Apr;53:745-50. No abstract available.

48.

ACTINOMYCIN SENSITIVITY IN ESCHERICHIA COLI PRODUCED BY EDTA.

LEIVE L.

Biochem Biophys Res Commun. 1965 Jan 4;18:13-7. No abstract available.

PMID:
14265747

Supplemental Content

Support Center